PR Newswire PharmaOriginal article
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
specialty formulas for preterm infantsNeutral
AI Analysis
Summary
Abbott has reached settlement agreements to resolve litigation involving its specialty formulas for preterm infants, including the Gill case and claims from approximately 2,000 other individuals. Abbott maintains that its preterm infant formulas are safe and supported by regulatory and medical professionals.
Outcome Details
Settlement agreements reached to resolve Gill case and claims involving approximately 2,000 individuals
Importance:4/10
Sentiment:
0.20
litigationsettlementproduct safetypreterm infant formula
Related Companies
Read the original article
Published by PR Newswire Pharma on August 20, 2026 8:15 PM